Marshfield Clinic Research Institute is working with the North Central Cancer Treatment Group through the Alliance for Clinical Trials in Oncology on a new clinical trial for patients who will have a routine colonoscopy.
The study’s name is NCCTG-GLNE 010 Validation and Comparison of Biomarkers for the Early Detection of Colorectal Adenocarcinoma. That’s a scientific name for a study designed to see if stool, urine or blood can be used to find cancer as early as, or earlier than, a colonoscopy.
“Because people don’t like to get colonoscopies, they are at risk of not finding colon cancer early enough,” said Christopher Rall, M.D., Marshfield Clinic Marshfield Center gastroenterologist and principal investigator for this study.
Colon cancer is the second most common cancer in both men and women. It is curable if found early.
Study volunteers must be between ages 50 and 80, willing to provide blood, urine and stool samples, able to physically tolerate the removal of about three tablespoons of blood and able to come to Marshfield Center at least one week before their scheduled colonoscopy. Participation is just one visit and two stool samples collected at home for a total of an hour of time.
For additional information or to enroll in this study, contact research staff at 715-221-7336 or toll-free at 1-800-782-8581, ext. 1-7336.